2020 Revenues ($USD) : $4,275,000,000
2020 Revenues (foreign currencies) : €3,750,000,000
2020 R&D spend : not available
2020 Number of Employees : 17,650
Fiscal Year End : 12/31/2020
Key People : Elcin Barker Ergun, group CEO

The privately-held Italian company has been in the pharmaceuticals business for more than 125 years. It has a presence in over 100 countries, including a direct presence in over 70 countries. Menarini has products in the cardiovascular, gastroenterology, metabolic, infectious diseases and anti-inflammatory/analgesic space. It also has several new investigational cancer drugs in development. –CN